Cargando…

SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

This study aimed to evaluate changes of the lipid panel data in patients with comorbid type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SCH) and to identify the probable prognostic values of the lipid profile for macrovascular complication (MVC) development. The study included 370 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Marushchak, Mariya, Vivsiana, Iryna, Musiienko, Volodymyr, Krynytska, Inna, Kozak, Kateryna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907953/
https://www.ncbi.nlm.nih.gov/pubmed/35282484
http://dx.doi.org/10.20471/acc.2021.60.03.20
_version_ 1784665769009741824
author Marushchak, Mariya
Vivsiana, Iryna
Musiienko, Volodymyr
Krynytska, Inna
Kozak, Kateryna
author_facet Marushchak, Mariya
Vivsiana, Iryna
Musiienko, Volodymyr
Krynytska, Inna
Kozak, Kateryna
author_sort Marushchak, Mariya
collection PubMed
description This study aimed to evaluate changes of the lipid panel data in patients with comorbid type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SCH) and to identify the probable prognostic values of the lipid profile for macrovascular complication (MVC) development. The study included 370 patients presented with only T2DM and 30 patients suffering from both T2DM and SCH. Receiver operating characteristic (ROC) analysis was used to identify prognostically significant values of the lipid profile with the optimal ratio of sensitivity and specificity for MVC development. All lipid profile values in the patients with T2DM combined with SCH were significantly higher compared to those with only T2DM. At the same time, SCH + T2DM increased the risk of exceeding target levels of triglycerides by 2.9 times and HDL-C by 4.1 times. Analysis of lipid profile values according to macrovascular involvement showed that total cholesterol, LDL-C and non-HDL-C in patients with T2DM and SCH were significantly higher compared to those with only T2DM. The levels of triglycerides >1.65 mmol/L, non-HDL-C >3.74 mmol/L and remnant cholesterol >0.74 mmol/L determined by the ROC analysis can be used for stratification of patients with T2DM combined with SCH into the category of increased risk of MVC development.
format Online
Article
Text
id pubmed-8907953
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
record_format MEDLINE/PubMed
spelling pubmed-89079532022-03-11 SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Marushchak, Mariya Vivsiana, Iryna Musiienko, Volodymyr Krynytska, Inna Kozak, Kateryna Acta Clin Croat Original Scientific Papers This study aimed to evaluate changes of the lipid panel data in patients with comorbid type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SCH) and to identify the probable prognostic values of the lipid profile for macrovascular complication (MVC) development. The study included 370 patients presented with only T2DM and 30 patients suffering from both T2DM and SCH. Receiver operating characteristic (ROC) analysis was used to identify prognostically significant values of the lipid profile with the optimal ratio of sensitivity and specificity for MVC development. All lipid profile values in the patients with T2DM combined with SCH were significantly higher compared to those with only T2DM. At the same time, SCH + T2DM increased the risk of exceeding target levels of triglycerides by 2.9 times and HDL-C by 4.1 times. Analysis of lipid profile values according to macrovascular involvement showed that total cholesterol, LDL-C and non-HDL-C in patients with T2DM and SCH were significantly higher compared to those with only T2DM. The levels of triglycerides >1.65 mmol/L, non-HDL-C >3.74 mmol/L and remnant cholesterol >0.74 mmol/L determined by the ROC analysis can be used for stratification of patients with T2DM combined with SCH into the category of increased risk of MVC development. Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2021-09 /pmc/articles/PMC8907953/ /pubmed/35282484 http://dx.doi.org/10.20471/acc.2021.60.03.20 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Original Scientific Papers
Marushchak, Mariya
Vivsiana, Iryna
Musiienko, Volodymyr
Krynytska, Inna
Kozak, Kateryna
SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_full SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_fullStr SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_full_unstemmed SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_short SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_sort subclinical hypothyroidism as a contributor to macrovascular complications in patients with type 2 diabetes mellitus
topic Original Scientific Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907953/
https://www.ncbi.nlm.nih.gov/pubmed/35282484
http://dx.doi.org/10.20471/acc.2021.60.03.20
work_keys_str_mv AT marushchakmariya subclinicalhypothyroidismasacontributortomacrovascularcomplicationsinpatientswithtype2diabetesmellitus
AT vivsianairyna subclinicalhypothyroidismasacontributortomacrovascularcomplicationsinpatientswithtype2diabetesmellitus
AT musiienkovolodymyr subclinicalhypothyroidismasacontributortomacrovascularcomplicationsinpatientswithtype2diabetesmellitus
AT krynytskainna subclinicalhypothyroidismasacontributortomacrovascularcomplicationsinpatientswithtype2diabetesmellitus
AT kozakkateryna subclinicalhypothyroidismasacontributortomacrovascularcomplicationsinpatientswithtype2diabetesmellitus